Nexalin Technology, Inc. (NXL) Key Metrics

NASDAQ: NXLValuation, returns, debt and efficiency ratios over 7 years.

NXL valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$2.5M
Enterprise value
$3.0M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
11.3
10-yr median 28.6
Price / book
2.6
10-yr median 1.7
EV / EBITDA
0.0
Dividend yield
—
Beta
4.11

NXL key metrics, 2019–2025

Fiscal year ended December 31, 2025 · U.S. dollars

NXL valuation Price multiples at each fiscal year-end price.

Price / sales−79.9%
30.3
2025 · hover or tap a bar for each year
2022: 4.12023: 26.9 (+551.4%)2024: 150.8 (+460.3%)2025: 30.3 (−79.9%)
20192025
Price / book−64.7%
2.4
2025 · hover or tap a bar for each year
2022: 1.02023: 0.9 (−6.7%)2024: 6.9 (+644.7%)2025: 2.4 (−64.7%)
20192025
Free cash flow yield−38.0 pts
−54.2%
2025 · hover or tap a bar for each year
2022: −40.6%2023: −132.4% (−91.8 pts)2024: −16.2% (+116.2 pts)2025: −54.2% (−38.0 pts)
20192025

NXL valuation history

Fiscal year-endToday7-year median

NXL returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

NXL debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

NXL price vs earnings per share

Share price at year-endEPS (right axis)

NXL key metrics

2019–2025
Nexalin Technology, Inc. key metrics by fiscal year
2025202420232022202120202019
Valuation
Market capitalization$9.1M$25.4M$3.0M$5.5M———
Enterprise value$5.4M$22.0M$35,623−$781,049———
Price / sales30.3150.826.94.1———
Price / book2.46.90.91.0———
EV / sales18.0130.10.3-0.6———
Earnings yield−89.9%−29.9%−156.0%−31.1%———
Free cash flow yield−54.2%−16.2%−132.4%−40.6%———
Share price at fiscal year-end$16.74$82.80$12.15$22.47———
Per share
Revenue per share$0.55$0.55$0.45$5.44$0.59$1.00$0.85
Earnings per share−$15.05−$24.76−$18.96−$6.99−$25.05−$14.03−$20.69
Operating cash flow per share−$9.07−$12.84−$15.64−$9.12−$4.44−$3.56−$2.80
Free cash flow per share−$9.07−$13.39−$16.09−$9.12−$4.44−$3.56−$2.80
Cash per share$6.81$11.33$12.02$28.80$2.73$0.32$0.26
Book value per share$6.86$11.97$13.08$22.56−$6.93−$6.55−$4.86
Tangible book value per share$6.24$11.12$12.65$22.56−$6.93−$6.55−$4.86
Capex per share$0.18$0.55$0.45$0.00$0.00$0.00$0.00
Debt per share——$0.02$3.11$3.50$2.99$3.41
Shares outstanding546K307K245K243K243K243K243K
Change in shares outstanding+77.9%+25.3%+1.0%+0.1%0.0%0.0%—
Returns & profitability
Return on equity (ROE)−221.5%−221.1%−107.0%−89.4%———
Return on assets (ROA)−185.6%−193.7%−84.0%−41.5%———
Return on tangible assets−191.2%−192.0%−131.8%−22.8%−806.4%——
Free cash flow margin———−167.7%−747.4%−355.7%−327.1%
Financial health
Total debt——$4,463$755,260$850,050$726,012$826,766
Cash & short-term investments$3.7M$3.5M$2.9M$7.0M$661,778$78,436$63,427
Net debt−$3.7M−$3.5M−$2.9M−$6.2M$188,272$647,576$763,339
Debt / equity——0.000.14———
Debt / assets——0.000.101.136.137.35
Current ratio4.857.258.073.810.320.070.11
Quick ratio4.706.937.703.730.310.060.09
Interest coverage——-146.7-30.9-73.1-41.4-18.1
Working capital$3.4M$3.4M$3.0M$5.5M−$1.6M−$1.4M−$930,730
Invested capital$24,774$196,115$262,665−$759,988−$1.5M−$942,754−$416,032
Tangible asset value$3.4M$3.4M$3.1M$5.5M−$1.7M−$1.6M−$1.2M
Net current asset value$3.4M$3.4M$3.0M$5.5M−$1.7M−$1.6M−$1.2M
Graham net-net per share$5.42$9.86$10.64$21.09−$7.19−$6.65−$5.00
Capital allocation
Capex / revenue32.1%100.9%98.7%0.0%0.0%0.3%0.0%
Capex / depreciation4.5011.2725.690.000.001.510.01
Stock-based compensation / revenue1,035.4%2,110.3%2,179.2%20.5%3,108.3%806.7%271.4%
R&D / revenue359.2%705.9%1,735.5%38.7%96.5%——
SG&A / revenue2,502.1%3,968.6%3,485.0%211.2%4,262.8%1,433.8%701.8%
Efficiency
Days sales outstanding57.224.223.52.929.09.210.0
Days of inventory on hand910.11,650.82,208.093.3460.2278.136.1
Days payables outstanding1,191.01,573.45,810.8754.811,106.94,937.4542.7
Cash conversion cycle (days)-223.7101.6-3,579.3-658.5-10,617.7-4,650.1-496.6
Receivables turnover6.3815.0615.55124.7912.5839.5336.45
Payables turnover0.310.230.060.480.030.070.67
Inventory turnover0.400.220.173.910.791.3110.10
Asset turnover0.070.040.020.320.332.101.84
Average receivables$47,307$11,206$7,122$10,589$11,451$6,144$5,690
Average payables$200,264$157,742$408,950$751,080$652,478$392,816$324,470
Average inventory$153,026$165,499$155,395$92,890$27,033$22,127$21,598
Intangibles / total assets7.2%6.2%2.9%0.0%0.0%0.0%0.0%

Computed from NXL's annual financial statements (latest annual report filed March 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

NXL valuation and financial ratios

Nexalin Technology earned a return on equity of −221.5% in fiscal 2025. The share count rose 125.2% from 243K to 546K over 6 years.

See the NXL income statement, the NXL chart for price history, or the NXL stock overview for the latest quote and news.

NXL key metrics FAQ

What is Nexalin Technology's return on equity?

Nexalin Technology's return on equity (ROE) was −221.5% in fiscal 2025: net income of -$8.2 million on average shareholders' equity of $3.7 million.

What is Nexalin Technology's free cash flow yield?

Nexalin Technology generated -$5.0 million of free cash flow in fiscal 2025, a free cash flow yield of −54.2% on its market value at year-end ($9.1 million).

What is Nexalin Technology's current ratio?

Nexalin Technology's current ratio was 4.85 at the end of fiscal 2025: current assets were 4.85 times current liabilities.

Medical Devices key metrics